So, if you've had problems with low blood sugar in the past, your doctor will need to be careful when deciding if this medication is right for you
Tirzepatide is newer, with FDA approval for weight loss (as Zepbound) coming in late 2023
What the Ozempic Label Does and Does Not Cover An indication is a regulatory statement about the population and purpose for which a manufacturer submitted evidence and the FDA agreed the benefit-risk balance was favorable
As clinicians face patients who plateau on standard regimens, the question becomes not just whether to escalate, but how to do so safely and effectively
Large CPG companies like Nestl see this trend as an opportunity to develop new, nutrient-rich, healthier companion GLP-1 products. In May 2024, Nestl launched its first GLP-1 companion brand, Vital Pursuit, which consists of portion-aligned foods high in protein and essential nutrients
Twists and turns